Product Information

VENLAFAXINE BES ER 112.5 MG TB is a generic product labeled by Almatica Pharma LLC, priced at $6.4116 per EA under NDC 52427063230. Its NADAC has been published 136 times since Apr 17, 2024.

FDA first approved this application on Jun 29, 2022.

The High Outlier badge above means this manufacturer's average price in the venlafaxine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

VENLAFAXINE BES ER 112.5 MG TB

venlafaxine
$6.4116per EA
High Outlier

Strength

112.5 mg/1

NDC

52427063230

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Approval Type

New Drug (NDA)

FDA Application

NDA215429

FDA Approved

6/29/2022

On Market Since

6/30/2022

Pharmacological Classes

Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price Statistics

The NADAC for VENLAFAXINE BES ER 112.5 MG TB has been published 136 times since Apr 17, 2024, and over the history we have for it it has risen 3.3%. The table below summarizes its recorded NADAC range and movement.

Current price$6.4116 per EA
All-time high$6.4116 (Nov 18, 2026)
All-time low$6.1722 (Apr 22, 2026)
52-week high$6.4116
52-week low$6.1722
Median price$6.1903
Average price$6.1975
Largest weekly change+1.6% (Nov 18, 2026)
Weeks tracked136
Tracking sinceApr 17, 2024

Price History

1W

+1.6%

1M

+2.9%

3M

+3.7%

6M

+3.8%

1Y

+3.6%

3Y

N/A

5Y

N/A

All

+3.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the venlafaxine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VENLAFAXINE BES ER 112.5 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE BES ER 112.5 MG TB, manufactured by Almatica Pharma LLC, is $6.4116 per EA (NDC 52427063230), effective Nov 18, 2026.

How has the price of VENLAFAXINE BES ER 112.5 MG TB changed over time?

Over the history we have for it, the NADAC for VENLAFAXINE BES ER 112.5 MG TB has risen 3.3%. It has been tracked across 136 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for VENLAFAXINE BES ER 112.5 MG TB?

Since Apr 17, 2024, the NADAC for VENLAFAXINE BES ER 112.5 MG TB has ranged from a low of $6.1722 (Apr 22, 2026) to a high of $6.4116 (Nov 18, 2026), with a median of $6.1903 per EA.

Are there cheaper alternatives to VENLAFAXINE BES ER 112.5 MG TB?

No other NADAC-published product currently shares the active ingredient and strength of VENLAFAXINE BES ER 112.5 MG TB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures VENLAFAXINE BES ER 112.5 MG TB?

VENLAFAXINE BES ER 112.5 MG TB (NDC 52427063230) is labeled by Almatica Pharma LLC, and CMS classifies it as a generic product.